PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
|Articles|February 2, 2019
- Pharmaceutical Technology-02-02-2019
- Volume 43
- Issue 2
Multi-Shaft Mixer and Disperser
The Ross VersaMix is a multi-shaft mixer suited for viscous applications requiring a high level of accuracy and batch-to-batch consistency.
The Ross VersaMix is a multi-shaft mixer suited for viscous applications requiring a high level of accuracy and batch-to-batch consistency.
Available in standard sizes from 1- to 4000-gallon capacity, the mixer offers simple and reliable scalability from product development to full-scale production. Two or three independently-driven agitators work in tandem to ensure high-speed fine dispersion, efficient turnover, and uniform heating/cooling. Mixer features are tailored to a specific formulation or range of products for maximum functionality.
The VMC-200 model has a maximum working capacity of 200 gallons. An air/oil lift raises and lowers the agitators into the vacuum-rated vessel. All product contact surfaces are stainless-steel type 316L polished 180-grit finish. The ASME 60-psi jacket on the vessel is insulated with two-inch thick mineral wool and sheathed with water-tight stainless-steel cladding.
Equipped with a 10HP anchor agitator, 20HP disperser, and 25HP rotor/stator, the mixer delivers a combination of laminar bulk flow and intensity necessary for homogenization and deagglomeration in high-viscosity conditions up to several hundred thousand centipoises. The vacuum cover includes multiple charging ports, viewing windows, tank light, and a thermoprobe. Finished product is discharged out of a three-inch pneumatically-actuated diaphragm valve installed on the tank’s conical bottom.
Articles in this issue
over 7 years ago
Spectroscopy Facilitates Lean Analysisover 7 years ago
Fundamentals of GMP Warehouse Designover 7 years ago
Effective Root Cause Determinationover 7 years ago
Process Development Best Practices for Topical Drug Productsover 7 years ago
FDA Promotes Quality Standards to Reduce Shortagesover 7 years ago
Small-Batch Aseptic Fill/Finish Systemover 7 years ago
Automatic Desiccant Inserterover 7 years ago
Sterile Boot Coversover 7 years ago
Innovations Maintain the Cold Chainover 7 years ago
Advances in Engineering of Protein-Based APIsRelated to this article
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.